BioElectronics Obtains Additional US Patent For Its Unique Pain Devices
FREDERICK, Md., April 1, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics, announced today that the Company has received notice from the United States Patent and Trademark Office that patent number 8,412,328 is being issued.
This new US patent, our five other US patents, and two pending provide us sound intellectual property protection. This patent includes specific disease state coverage for therapeutic treatments to reduce pain and inflammation. The engineering and therapeutic claims collectively cover long lasting pain relief that is 5x better than OTC drugs, 100% safer, and cost less than $0.25 for overnight pain relief. These patents, other intellectual property, and sound clinical research provides a viable inexpensive pain therapy for the hundreds of millions of chronic pain suffers worldwide without the detrimental side effects or risk of addiction of other pain therapies.
"We appreciate the importance of protecting our intellectual property both with patents, continual innovation, and our disruptive marketing strategy," said John Martinez , Director of Engineering at BioElectronics. "This patent and our portfolio of international patents provide confirmation of our sound science and the value of our accumulated body of knowledge."
About BioElectronics Corporation
BioElectronics is an award winning developer and manufacturer of clinically proven advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and chronic wound care. For additional information, please see our web site www.bielcorp.com.